{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:47:48Z","timestamp":1761662868850},"reference-count":16,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T00:00:00Z","timestamp":1277424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Dermatology"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chelated zinc\u2013carnosine and vitamin E [GastriCalm<jats:sup>\u00ae<\/jats:sup> (GCM); Teva Animal Health] is marketed as an anti\u2010emetic supplement for dogs to assist the repair of damaged stomach and intestinal mucosa. The purpose of this prospective, double\u2010blinded, placebo\u2010controlled trial was to determine whether GCM reduced the frequency of vomiting, diarrhoea and appetite changes during initiation of ciclosporin (Atopica<jats:sup>\u00ae<\/jats:sup>; Novartis Animal Health) therapy for the treatment of canine atopic dermatitis. Sixty privately owned dogs diagnosed with atopic dermatitis were randomly assigned to GCM (<jats:italic>n<\/jats:italic>\u2003=\u200330) or placebo (<jats:italic>n<\/jats:italic>\u2003=\u200330) groups. All dogs received \u223c5\u2003mg\/kg ciclosporin (range, 3.5\u20135.8\u2003mg\/kg) once daily. Dogs &lt;13.6\u2003kg received half a tablet of GCM or placebo; dogs \u226513.6\u2003kg received one tablet once daily. GastriCalm<jats:sup>\u00ae<\/jats:sup> or placebo was administered 30\u2003min prior to eating, and the ciclosporin was administered 2\u2003h after feeding. Owners recorded episodes of vomiting, diarrhoea and appetite changes. Dogs were examined on days 0 and 14. Forty\u2010one of 60 dogs (68.3%) had at least one episode of vomiting, diarrhoea or appetite change, leaving nine placebo dogs (30%) and ten GCM dogs (33.3%) free of adverse events (AE). Twenty\u2010seven of 60 dogs (45%) vomited, and 15 of 60 (25%) had diarrhoea. There was no significant difference in episodes of individual AEs, but the placebo group had a significantly lower total AE score (summation of episodes of appetite change, vomiting and diarrhoea; <jats:italic>P<\/jats:italic>\u2003=\u20030.022). Small dogs (&lt;6.82\u2003kg) had significantly fewer total AEs in both treatment groups and tolerated ciclosporin better than larger dogs (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05).<\/jats:p>","DOI":"10.1111\/j.1365-3164.2010.00910.x","type":"journal-article","created":{"date-parts":[[2010,6,25]],"date-time":"2010-06-25T10:07:29Z","timestamp":1277460449000},"page":"53-60","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Zinc\u2013carnosine and vitamin E supplementation does not ameliorate gastrointestinal side effects associated with ciclosporin therapy of canine atopic dermatitis"],"prefix":"10.1111","volume":"22","author":[{"given":"Laura S.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne S.","family":"Rosenkrantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Roycroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,13]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(01)00343-9"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(01)00345-2"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.148.21.662"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2002.221.370"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.2002.00283.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.2003.00318.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.154.22.681"},{"key":"e_1_2_6_9_2","first-page":"854","article-title":"Influence of food intake on the clinical response to cyclosporine\u2003A in canine atopic dermatitis","volume":"159","author":"Thelen A","year":"2006","journal-title":"Veterinary Record"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2005.00491.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.2460\/javma.2005.226.1855"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.099929"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005566406257"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1356.013"},{"key":"e_1_2_6_15_2","first-page":"52","article-title":"Toxicity of the novel anti\u2010peptic ulcer agent polaprezinc in beagle dogs","volume":"45","author":"Matsuda K","year":"1995","journal-title":"Arzneimittel-Forschung"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(07)76001-6"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.2003.00317.x"}],"container-title":["Veterinary Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3164.2010.00910.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3164.2010.00910.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T12:36:07Z","timestamp":1697286967000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3164.2010.00910.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,13]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1365-3164.2010.00910.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3164.2010.00910.x","archive":["Portico"],"relation":{},"ISSN":["0959-4493","1365-3164"],"issn-type":[{"value":"0959-4493","type":"print"},{"value":"1365-3164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,13]]},"assertion":[{"value":"2011-01-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}